COMMUNIQUÉS West-GlobeNewswire
-
New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted
20/11/2018 - 08:30 -
OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Initiation of Phase 2 Clinical Trial to Evaluate Tedopi® in Combination with Opdivo® (nivolumab) in Pancreatic Cancer
20/11/2018 - 08:00 -
Rule 2.9 Announcement
20/11/2018 - 08:00 -
DBV Technologies Presents Data at ACAAI 2018 on Investigational Viaskin Peanut for the Treatment of Peanut-Allergic Children
20/11/2018 - 07:31 -
DBV Technologies présente à l'ACAAI 2018 des données relatives à Viaskin Peanut, un médicament expérimental pour le traitement de l'allergie à l'arachide chez les enfants
20/11/2018 - 07:31 -
Innate Pharma appoints experts to new Strategic Advisory Board
20/11/2018 - 07:01 -
Innate Pharma nomme son nouveau Conseil Stratégique composé d'experts en immuno-oncologie
20/11/2018 - 07:01 -
Avivagen Announces Clarification to Press Release Issued November 19, 2018
20/11/2018 - 01:20 -
Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder
20/11/2018 - 00:46 -
R1 RCM to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018 - 00:12 -
Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule and Intention to Initiate Patient Studies in Multiple Indications in Collaboration With Sanofi
19/11/2018 - 22:30 -
Progenics Pharmaceuticals Announces Presentation of Updated Safety and Tolerability Data for AZEDRA® (iobenguane I 131) at the Radiological Society of North America (RSNA) Annual Meeting
19/11/2018 - 22:30 -
XOMA Announces Commencement of Rights Offering
19/11/2018 - 22:30 -
Emergent BioSolutions and Valneva Report Positive Phase 1 Results for Their Vaccine Candidate Against the Zika Virus
19/11/2018 - 22:22 -
Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference
19/11/2018 - 22:21 -
Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Portuguese Hemp Company
19/11/2018 - 22:21 -
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
19/11/2018 - 22:16 -
EMERGENT BIOSOLUTIONS AND VALNEVA REPORT POSITIVE PHASE 1 RESULTS FOR THEIR VACCINE CANDIDATE AGAINST THE ZIKA VIRUS
19/11/2018 - 22:16 -
Emergent BioSolutions et Valneva annonçent des résultats positifs de Phase 1 pour leur candidat vaccin contre le virus Zika
19/11/2018 - 22:16
Pages